Non-dopaminergic therapies

John G. Nutt, Nicolaas I. Bohnen

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations


Currently all aspects of Parkinson's disease (PD) treatment are less than ideal and would benefit from new interventions. We focus on problems associated with brain neurotransmitters amenable to more specific subreceptor and temporal manipulation. In addition, we consider potentially treatable CNS non-PD co-pathologies or co-morbidities that may exacerbate progression of various aspects of PD.

Original languageEnglish (US)
Pages (from-to)S73-S78
JournalJournal of Parkinson's Disease
Issue numbers1
StatePublished - 2018


  • Acetylcholine
  • Cognition
  • Diabetes mellitus
  • Falls
  • Freezing of gait
  • GABA
  • GBA
  • Glymphatic clearance
  • Small vessel disease
  • β-amyloid

ASJC Scopus subject areas

  • Clinical Neurology
  • Cellular and Molecular Neuroscience


Dive into the research topics of 'Non-dopaminergic therapies'. Together they form a unique fingerprint.

Cite this